Amandeep Godara is an Oncology physician affiliated with University of Utah. OpenAlex indexes 112 publications with 770 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2000 Circle Of Hope Dr
Salt Lake City, UT 841125550
Telephone
801-646-4098Provider last certified this registry record 2 Nov 2021.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20251 payment
- GENZYME CORPORATIONProgram year20251 payment
- GENZYME CORPORATIONProgram year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
31.3%Thalidomide Analog26%Revlimid80%Pomalyst13%Lenalidomide8%Part D<11 patientsKinase inhibitor5.3%Brukinsa100%Part D<11 patientsDermatology
29.8%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor29.8%Acyclovir100%Part D≥65 patientsMetabolism & gastrointestinal
11.7%Proton pump inhibitor8.5%Omeprazole100%Part D≥23 patientsPotassium supplement2.1%Potassium Chloride100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network
2026 - Immune-Effector Cell-Associated Enteritis/Colitis (IEC-EC) after Ciltacabtagene Autoleucel (cilta-cel) in Multiple Myeloma (MM): Updated Clinicopathologic Data and Management
Biology of Blood and Marrow Transplantation
2026 - NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025
Journal of the National Comprehensive Cancer Network
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Colman, MD
University of Utah
Michael Varner, MD
University of Utah
James Fang
University of Utah
Wallace Akerley, MD
University of Utah
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”